Clinical trial
Randomized Continuation, Dose Escalation Trial of Sorafenib in Patients With Advanced HCC With Radiological Progression on Prior Sorafenib Treatment (Phase II Study)
NCT00490685 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Continuation, Dose Escalation Trial of Sorafenib in Patients With Advanced HCC With Radiological Progression on Prior Sorafenib Treatment (Phase II Study)
- Lead sponsor
- Istituto Clinico Humanitas
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- Not reported
- Enrollment
- 142 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.